SlideShare a Scribd company logo
VALUE IN HEALTH 14 (2011) A1–A214                                                                          A25


termination. CONCLUSIONS: Clinical trial learning curves have significant impli-              were published in 15 different journals all based outside of Russia between 1994
cations for outcomes research accuracy, patient safety, and overall trial success.           and 2009. On average, each article was written by seven authors. Most first authors
Clinical trial simulation may provide a broadly applicable methodology for ad-               had medical/clinical training and resided in the USA (n 8) at the time of publica-
dressing several factors associated with clinical trial learning curve effects and for       tion of the study. Based on a scale of 1–10, with 10 indicating the highest quality, the
improving the accuracy of clinical trial outcomes.                                           mean quality score for all studies was 8.09 (SD 1.29) and 25% of the articles were
                                                                                             of fair quality (score 5–7). The quality of articles was statistically significantly re-
PHP75
                                                                                             lated (P 0.05) to the primary health intervention (pharmaceuticals non-phar-
USE OF ELECTRONIC MEDICAL RECORDS FROM 2001 THROUGH 2010:
                                                                                             maceuticals) and primary training of the first author (medical            non-medical).
IMPLICATIONS FOR COMPARATIVE EFFECTIVENESS RESEARCH
                                                                                             CONCLUSIONS: The conduct of health economics and pharmacoeconomics research
Anastassopoulos KP1, Mann R2, Knight TG1, Sudharshan L1, Ackerman SJ2
1                                                                                            in Russia in the English language is limited and, on average, the published articles
 Covance Market Access Services, Inc., Gaithersburg, MD, USA, 2Covance Market Access
Services, Inc., San Diego, CA, USA
                                                                                             were of good quality. However, about one-quarter of published articles were of fair
OBJECTIVES: Recent developments in the United States (US) health care reform                 quality. More health economics research in English is warranted in Russia.
and funding for comparative effectiveness research suggest that use of electronic            PHP78
medical records (EMR) in outcomes research may increase over time. EMR can be                CHARACTERISTICS OF HOMELESS INDIVIDUALS USING INPATIENT AND
particularly useful when outcomes are not well-defined with diagnosis or proce-               EMERGENCY DEPARTMENT SERVICES
dures codes or when clinical data are needed. The objective of this study was to             Karaca Z, Wong H, Mutter R
review trends in the use of EMR during the past decade. METHODS: A review of                 Agency for Healthcare Research and Quality (AHRQ), Rockville, MD, USA
published literature was conducted in PubMed for years 2001 through 2010 to iden-            OBJECTIVES: This study compares the patient characteristics, insurance coverage,
tify outcomes studies in the US that used EMR. Internal quality assurance studies            disease prevalence, and utilization patterns of inpatient and emergency depart-
and validation studies that used EMR were excluded. The number of studies, set-              ment (ED) services between homeless and non-homeless people using a new data
ting of care, patient population, whether the study was comparative, and any noted           source that has not been employed in existing studies. METHODS: A retrospective
limitations were examined. RESULTS: A total of 58 EMR-based, outcomes studies in             data analysis was conducted to compare differences in patient characteristics,
the US were identified over the past decade; increasing from 3 in 2001 to 12 in 2010.         insurance coverage, disease prevalence, and utilization patterns between home-
The majority of studies included outpatient EMR. Studies included a variety of               less and non-homeless individuals who visited a hospital or hospital-based emer-
patient populations with over one-third in cardiovascular disease, psychiatric dis-          gency department. For each service type, separate rates were created for homeless
ease, and diabetes combined. The percent of studies that were comparative ranged             and non-homeless populations and then compared. The Healthcare Cost and Uti-
from 0% in 2001 to 45% in 2010. Measures of effectiveness varied widely and in-              lization Project (HCUP) State Inpatient Databases (SID) and State Emergency De-
cluded lab values, clinical measures, and health-related quality-of-life outcomes.           partment Databases (SEDD) for 2008 were used in the analysis. The SID employed in
Some noted limitations on the use of EMR data in outcomes research included lack             this study include 15.9 million inpatient hospital discharges from community hos-
of representativeness of all care delivered across practice settings, lack of general-       pitals in ten states – Arizona, California, Colorado, Florida, Georgia, Massachusetts,
izability and standardization, and reliance on health care provider reporting.               Missouri, New York, Pennsylvania and Wisconsin. 177,056 of these discharges were
CONCLUSIONS: Although the use of EMR in outcomes research has increased                      homeless patients. The SEDD employed in this study include 23.7 million visits to
slowly in the past decade, the proportion of comparative studies using EMR has               ED, where patients were treated and released, from seven states (i.e., Arizona,
increased over time. As the industry works to standardize EMR and more advanced              Florida, Georgia, Massachusetts, Missouri, New York and Wisconsin). 49,595 of
outcomes are collected in EMR systems, EMR data may play a larger role in com-               these visits were homeless patients. RESULTS: The uninsured homeless (non-
parative effectiveness research.                                                             homeless) patients were accountable for 28.1% (4.6%) of inpatient admissions and
                                                                                             42.85 (21%) of ED visits. Medicaid covered 48.2% of all inpatient discharges and
PHP76
                                                                                             34.7% of all ED visits by homeless patients. 73.7% (50.6%) of homeless (non-home-
THE OUTLOOK OF LARGE SIMPLE TRIALS FOR COMPARATIVE EFFECTIVENESS                             less) inpatient admissions came through EDs. Homeless patients with mental dis-
RESEARCH: AN APPLICATION OF THE PRECIS FRAMEWORK                                             orders accounted for 22.4% of all homeless inpatient discharges and 49% of all
Vincent L
                                                                                             homeless ED visits. A majority of the mental disorder diagnosis in both settings of
Quintiles Global Consulting, Hawthorne, NY, USA
                                                                                             care were alcohol-related disorders, mood disorders, and schizophrenia.
OBJECTIVES: In recent years, comparative effectiveness research (CER) has gained
                                                                                             CONCLUSIONS: The profile of homeless and non-homeless patients differed sig-
increasing interest and investment across major life science and health policy
                                                                                             nificantly by insurance status and by race in both the inpatient and emergency
stakeholder groups: regulators, biopharmaceuticals, physicians, patients, and pay-
                                                                                             department settings.
ers. One method, large simple trial (LST), a hybrid of observational cohort study and
randomized control trial (RCT), is designed for large numbers of patients in post-           PHP79
approval research and is a choice study design for comparing the relative strengths          ROLE OF HTA SYSTEMS IN REIMBURSEMENT AND MARKET ACCESS:
and weaknesses of medical interventions. The objective of this study was to eval-            COMPARISON OF TURKEY AND POLAND
uate the current landscape of LSTs to capture key themes in the future outlook of            Kirpekar S, Shankland B, Dummett H
CER. METHODS: A structured abstract review and funnel analysis was conducted                 Double Helix Consulting, London, UK
using data available through ClinicalTrials.gov. Using the search terms, “phase IV”,         OBJECTIVES: Health economies outside Western Europe are increasingly adopting
“post-marketing”, “randomized”, and “multi-centered”, 2230 clinical trials were              evidence-based decision-making, but implementation methods differ. Common-
filtered with restricted parameters for number of patients (n 1000), evidence of              alities in the approach taken in Turkey and Poland nevertheless illustrate the role
blinding, stated objective of comparative effectiveness, and date of trial initiation.       of a previously developed reimbursement process in the adoption of HTA. Insights
RESULTS: To gain a perspective on current and future outlook, only trials initiated          from this comparison may have implications for industry, government and private
between 2009 and 2010 (n 10) were assessed in this phase of study. Using the                 reimbursement authorities worldwide. METHODS: Turkey and Poland were se-
Pragmatic Explanatory Continuum Indicator Summary (PRECIS) framework origi-                  lected for comparison due to their relatively recent adoption of HTA within an
nally developed for pragmatic trials, the analysis revealed an important theme.              established reimbursement system. A total of 18 stakeholders were interviewed via
When applying key domain criteria – practitioner expertise, treatment flexibility,            telephone interviews to understand current and future utilisation of HTA in reim-
eligibility criteria, health outcomes, study duration, intent-to-treat (ITT), and pri-       bursement. The study evaluated the impact of the following decision-making do-
mary outcome analysis, as defined by the PRECIS framework – less than 50% of the              mains: clinical differentiation, prioritisation of unmet needs, price, and presenta-
LST CER trials were designed to measure effectiveness, as opposed to efficacy.                tion requirements (e.g. budget impact analysis). A comparison was then made on a
CONCLUSIONS: According to findings, there has been an uptake on the use of LSTs               rating scale devised to account for these influencing factors. RESULTS: In Turkey
in investigating the relative effectiveness of interventions. However, considering           the pharmacoeconomics unit of the Social Security Institute is responsible for
the increase in governmental pressure to reduce healthcare spending by improving             economic evaluation. However the Polish HTA body AHTAPol is more directly in-
quality of treatment; it is important that these LSTs are conducted to truly capture         volved in the HTA process. All 9 Polish respondents scored high on the influence of
effectiveness. For that reason, there is need for further research to extract and            HTA in access decisions while just 2 respondents in Turkey considered HTA to be
develop new frameworks for evaluation.                                                       extremely influential in reimbursement. However, pricing decisions in both coun-
                                                                                             tries are based on international referencing to varying degrees. CONCLUSIONS:
PHP77                                                                                        Despite superficial similarities in the structure of their reimbursement systems,
THE STATE OF HEALTH ECONOMICS AND PHARMACOECONOMICS RESEARCH                                 HTA in Poland is more closely integrated with decision making than in Turkey. At
IN RUSSIA: A SYSTEMATIC REVIEW                                                               present HTA plays a formal role in the Turkish system but a negotiation-based
Gavaza P1, Shepherd MD2, Shcherbakova N3, Khoza S3                                           approach remains to customary channel for value arguments. However, the rapid
1
 Appalachian College of Pharmacy, Oakwood, VA, USA, 2Center for Pharmacoeconomic Studies,
                                                                                             pace of change in the Turkish reimbursement system suggests the need for further
College of Pharmacy, University of Texas at Austin, Austin, TX, USA, 3Division of Pharmacy
                                                                                             ongoing research.
Administration, College of Pharmacy, University of Texas at Austin, Austin, TX, USA
OBJECTIVES: To investigate the state of health economic research in Russia avail-            PHP80
able in the English language by describing the number and characteristics of the             RELATIONSHIP OF HERBAL KNOWLEDGE TOWARDS ATTITUDE FORMATION
articles, and assessing the quality of these articles. METHODS: The study assessed           AMONG FUTURE PHARMACISTS
the state of health economics and pharmacoeconomics research in Russia. We                   Sura SD, Chabria A, Sansgiry S
conducted a literature search to identify health economics articles pertaining to            University of Houston, Houston, TX, USA
Russia. Each article in the final sample was scored by two reviewers independently            OBJECTIVES: Trends in the use of herbal medications continue to rise. Pharmacists
using the data-collection form designed for the study. RESULTS: In total, 16 studies         have an opportunity to provide consumers with evidence based information. This
investigating a wide variety of diseases were included in the study. These articles          study examined pharmacy student’s knowledge regarding herbal medication from

More Related Content

What's hot

Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology
ABUBAKRANSARI2
 
Adr project
Adr projectAdr project
Adr project
Anusha Rameshwaram
 
Metanalisis tratamientos ttm
Metanalisis tratamientos ttmMetanalisis tratamientos ttm
Metanalisis tratamientos ttm
Reynold Muñoz
 
Burry et al-2012-pediatric_blood_&_cancer
Burry et al-2012-pediatric_blood_&_cancerBurry et al-2012-pediatric_blood_&_cancer
Burry et al-2012-pediatric_blood_&_cancer
isabelerazochaves
 
Chapter 2.2 screening test
Chapter 2.2 screening testChapter 2.2 screening test
Chapter 2.2 screening test
Nilesh Kucha
 
Concept of risk in pharmacoepidemiology Presentation
Concept of risk in pharmacoepidemiology PresentationConcept of risk in pharmacoepidemiology Presentation
Concept of risk in pharmacoepidemiology Presentation
Mdshams244
 
Journal Club presentation in Nursing Research
Journal Club presentation in Nursing ResearchJournal Club presentation in Nursing Research
Journal Club presentation in Nursing Research
Dhara Vyas
 
Measurement of outcomes in pharacoepidemiology
Measurement of outcomes in pharacoepidemiologyMeasurement of outcomes in pharacoepidemiology
Measurement of outcomes in pharacoepidemiology
Dr. Ashish singh parihar
 
Preprint review article letter to all pharmacist 2016 pharmaceutical care la...
Preprint review article letter to all pharmacist 2016 pharmaceutical care  la...Preprint review article letter to all pharmacist 2016 pharmaceutical care  la...
Preprint review article letter to all pharmacist 2016 pharmaceutical care la...
M. Luisetto Pharm.D.Spec. Pharmacology
 
ECOGENE-21 translational research in genetics and omic sciences for applicati...
ECOGENE-21 translational research in genetics and omic sciences for applicati...ECOGENE-21 translational research in genetics and omic sciences for applicati...
ECOGENE-21 translational research in genetics and omic sciences for applicati...
Canadian Organization for Rare Disorders
 
Unit 1 pharmacoepidemiology
Unit 1 pharmacoepidemiologyUnit 1 pharmacoepidemiology
Unit 1 pharmacoepidemiology
Dr. Supriya Suman
 
Introduction to Pharmacoepidemiology
Introduction to PharmacoepidemiologyIntroduction to Pharmacoepidemiology
Introduction to PharmacoepidemiologyPerficient
 
INTERPROFESSIONAL COLLABORATION IN PHARMACOEPIDEMIOLOGY STUDIES
INTERPROFESSIONAL COLLABORATION IN PHARMACOEPIDEMIOLOGY STUDIES  INTERPROFESSIONAL COLLABORATION IN PHARMACOEPIDEMIOLOGY STUDIES
INTERPROFESSIONAL COLLABORATION IN PHARMACOEPIDEMIOLOGY STUDIES
Surya Amal
 
Homeopathic treatment of elderly patients - a prospective observational study...
Homeopathic treatment of elderly patients - a prospective observational study...Homeopathic treatment of elderly patients - a prospective observational study...
Homeopathic treatment of elderly patients - a prospective observational study...
home
 
Alcohol use and crash risk study
Alcohol use and crash risk studyAlcohol use and crash risk study
Alcohol use and crash risk study
Mr Christia
 
Nurse Staffing And Quality Of Careللطالب عامر آل الري
Nurse Staffing And  Quality Of Careللطالب عامر آل الريNurse Staffing And  Quality Of Careللطالب عامر آل الري
Nurse Staffing And Quality Of Careللطالب عامر آل الريTsega Tilahun
 
Precision Medicine: Opportunities and Challenges for Clinical Trials
Precision Medicine: Opportunities and Challenges for Clinical TrialsPrecision Medicine: Opportunities and Challenges for Clinical Trials
Precision Medicine: Opportunities and Challenges for Clinical Trials
Medpace
 
Prevention mrsa.ppt.shirlhooper
Prevention mrsa.ppt.shirlhooperPrevention mrsa.ppt.shirlhooper
Prevention mrsa.ppt.shirlhooper
Shirl Hooper
 

What's hot (20)

Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology
 
Adr project
Adr projectAdr project
Adr project
 
Metanalisis tratamientos ttm
Metanalisis tratamientos ttmMetanalisis tratamientos ttm
Metanalisis tratamientos ttm
 
Burry et al-2012-pediatric_blood_&_cancer
Burry et al-2012-pediatric_blood_&_cancerBurry et al-2012-pediatric_blood_&_cancer
Burry et al-2012-pediatric_blood_&_cancer
 
Chapter 2.2 screening test
Chapter 2.2 screening testChapter 2.2 screening test
Chapter 2.2 screening test
 
Concept of risk in pharmacoepidemiology Presentation
Concept of risk in pharmacoepidemiology PresentationConcept of risk in pharmacoepidemiology Presentation
Concept of risk in pharmacoepidemiology Presentation
 
Journal Club presentation in Nursing Research
Journal Club presentation in Nursing ResearchJournal Club presentation in Nursing Research
Journal Club presentation in Nursing Research
 
Measurement of outcomes in pharacoepidemiology
Measurement of outcomes in pharacoepidemiologyMeasurement of outcomes in pharacoepidemiology
Measurement of outcomes in pharacoepidemiology
 
Preprint review article letter to all pharmacist 2016 pharmaceutical care la...
Preprint review article letter to all pharmacist 2016 pharmaceutical care  la...Preprint review article letter to all pharmacist 2016 pharmaceutical care  la...
Preprint review article letter to all pharmacist 2016 pharmaceutical care la...
 
ECOGENE-21 translational research in genetics and omic sciences for applicati...
ECOGENE-21 translational research in genetics and omic sciences for applicati...ECOGENE-21 translational research in genetics and omic sciences for applicati...
ECOGENE-21 translational research in genetics and omic sciences for applicati...
 
Unit 1 pharmacoepidemiology
Unit 1 pharmacoepidemiologyUnit 1 pharmacoepidemiology
Unit 1 pharmacoepidemiology
 
Introduction to Pharmacoepidemiology
Introduction to PharmacoepidemiologyIntroduction to Pharmacoepidemiology
Introduction to Pharmacoepidemiology
 
INTERPROFESSIONAL COLLABORATION IN PHARMACOEPIDEMIOLOGY STUDIES
INTERPROFESSIONAL COLLABORATION IN PHARMACOEPIDEMIOLOGY STUDIES  INTERPROFESSIONAL COLLABORATION IN PHARMACOEPIDEMIOLOGY STUDIES
INTERPROFESSIONAL COLLABORATION IN PHARMACOEPIDEMIOLOGY STUDIES
 
Homeopathic treatment of elderly patients - a prospective observational study...
Homeopathic treatment of elderly patients - a prospective observational study...Homeopathic treatment of elderly patients - a prospective observational study...
Homeopathic treatment of elderly patients - a prospective observational study...
 
Alcohol use and crash risk study
Alcohol use and crash risk studyAlcohol use and crash risk study
Alcohol use and crash risk study
 
Nurse Staffing And Quality Of Careللطالب عامر آل الري
Nurse Staffing And  Quality Of Careللطالب عامر آل الريNurse Staffing And  Quality Of Careللطالب عامر آل الري
Nurse Staffing And Quality Of Careللطالب عامر آل الري
 
handoversrannals
handoversrannalshandoversrannals
handoversrannals
 
Cohort ppt
Cohort pptCohort ppt
Cohort ppt
 
Precision Medicine: Opportunities and Challenges for Clinical Trials
Precision Medicine: Opportunities and Challenges for Clinical TrialsPrecision Medicine: Opportunities and Challenges for Clinical Trials
Precision Medicine: Opportunities and Challenges for Clinical Trials
 
Prevention mrsa.ppt.shirlhooper
Prevention mrsa.ppt.shirlhooperPrevention mrsa.ppt.shirlhooper
Prevention mrsa.ppt.shirlhooper
 

Viewers also liked

Coesao e coerencia2552009145047
Coesao e coerencia2552009145047Coesao e coerencia2552009145047
Coesao e coerencia2552009145047
Gentelli Ifal Ifal
 
Hurley_BSLA320_Career_Portfolio
Hurley_BSLA320_Career_PortfolioHurley_BSLA320_Career_Portfolio
Hurley_BSLA320_Career_PortfolioNick Hurley
 
Figueroa palomo ukraine_v1
Figueroa palomo ukraine_v1Figueroa palomo ukraine_v1
Figueroa palomo ukraine_v1
ddcentr
 
Academie - cadouri Craciun
Academie - cadouri CraciunAcademie - cadouri Craciun
Academie - cadouri Craciun
SIlhouette
 
L'italia che dice sì - Il cartoncino
L'italia che dice sì - Il cartoncinoL'italia che dice sì - Il cartoncino
L'italia che dice sì - Il cartoncino
Partito democratico
 
e-Skills Match Project Factsheet (Spanish version)
e-Skills Match Project Factsheet (Spanish version) e-Skills Match Project Factsheet (Spanish version)
e-Skills Match Project Factsheet (Spanish version)
e-Skills Match
 
ROYAL CONSULTANTS PROVIDES STUDENT VISA SERVICES IN CHANDIGARH - INDIA
ROYAL CONSULTANTS PROVIDES STUDENT VISA SERVICES IN CHANDIGARH - INDIAROYAL CONSULTANTS PROVIDES STUDENT VISA SERVICES IN CHANDIGARH - INDIA
ROYAL CONSULTANTS PROVIDES STUDENT VISA SERVICES IN CHANDIGARH - INDIA
Visa Analyzer +91 81464 24000
 
Premio innova s@lute2016 FARMOSA
Premio innova s@lute2016 FARMOSAPremio innova s@lute2016 FARMOSA
Premio innova s@lute2016 FARMOSA
Noemi De Santis
 
слайди до лекції 03.05.15
слайди до лекції 03.05.15слайди до лекції 03.05.15
слайди до лекції 03.05.15
ddcentr
 
La revista escolar y revista escolar digital
La revista escolar y revista escolar digitalLa revista escolar y revista escolar digital
La revista escolar y revista escolar digitalNatalie Jane Evans
 
6 th sense technology
6 th sense technology6 th sense technology
6 th sense technology
kumbhar channu
 
Ef3e int quicktest_03_marking_overlay
Ef3e int quicktest_03_marking_overlayEf3e int quicktest_03_marking_overlay
Ef3e int quicktest_03_marking_overlay
Meryem Ozyel
 
Int plus entry checker key
Int plus entry checker keyInt plus entry checker key
Int plus entry checker key
eoihelen
 
Social Policy Analysis - Political Economy of Welfare
Social Policy Analysis - Political Economy of WelfareSocial Policy Analysis - Political Economy of Welfare
Social Policy Analysis - Political Economy of Welfare
University of York
 

Viewers also liked (17)

Coesao e coerencia2552009145047
Coesao e coerencia2552009145047Coesao e coerencia2552009145047
Coesao e coerencia2552009145047
 
Hurley_BSLA320_Career_Portfolio
Hurley_BSLA320_Career_PortfolioHurley_BSLA320_Career_Portfolio
Hurley_BSLA320_Career_Portfolio
 
Figueroa palomo ukraine_v1
Figueroa palomo ukraine_v1Figueroa palomo ukraine_v1
Figueroa palomo ukraine_v1
 
Academie - cadouri Craciun
Academie - cadouri CraciunAcademie - cadouri Craciun
Academie - cadouri Craciun
 
L'italia che dice sì - Il cartoncino
L'italia che dice sì - Il cartoncinoL'italia che dice sì - Il cartoncino
L'italia che dice sì - Il cartoncino
 
Publicación3
Publicación3Publicación3
Publicación3
 
e-Skills Match Project Factsheet (Spanish version)
e-Skills Match Project Factsheet (Spanish version) e-Skills Match Project Factsheet (Spanish version)
e-Skills Match Project Factsheet (Spanish version)
 
Informe 950
Informe 950Informe 950
Informe 950
 
ROYAL CONSULTANTS PROVIDES STUDENT VISA SERVICES IN CHANDIGARH - INDIA
ROYAL CONSULTANTS PROVIDES STUDENT VISA SERVICES IN CHANDIGARH - INDIAROYAL CONSULTANTS PROVIDES STUDENT VISA SERVICES IN CHANDIGARH - INDIA
ROYAL CONSULTANTS PROVIDES STUDENT VISA SERVICES IN CHANDIGARH - INDIA
 
Premio innova s@lute2016 FARMOSA
Premio innova s@lute2016 FARMOSAPremio innova s@lute2016 FARMOSA
Premio innova s@lute2016 FARMOSA
 
слайди до лекції 03.05.15
слайди до лекції 03.05.15слайди до лекції 03.05.15
слайди до лекції 03.05.15
 
La revista escolar y revista escolar digital
La revista escolar y revista escolar digitalLa revista escolar y revista escolar digital
La revista escolar y revista escolar digital
 
Inputs for CRG
Inputs for CRGInputs for CRG
Inputs for CRG
 
6 th sense technology
6 th sense technology6 th sense technology
6 th sense technology
 
Ef3e int quicktest_03_marking_overlay
Ef3e int quicktest_03_marking_overlayEf3e int quicktest_03_marking_overlay
Ef3e int quicktest_03_marking_overlay
 
Int plus entry checker key
Int plus entry checker keyInt plus entry checker key
Int plus entry checker key
 
Social Policy Analysis - Political Economy of Welfare
Social Policy Analysis - Political Economy of WelfareSocial Policy Analysis - Political Economy of Welfare
Social Policy Analysis - Political Economy of Welfare
 

Similar to Pharmaceutical Comparative Effectiveness Research Abstract

Application of Pharma Economic Evaluation Tools for Analysis of Medical Condi...
Application of Pharma Economic Evaluation Tools for Analysis of Medical Condi...Application of Pharma Economic Evaluation Tools for Analysis of Medical Condi...
Application of Pharma Economic Evaluation Tools for Analysis of Medical Condi...
IJREST
 
Ari Refs
Ari RefsAri Refs
Ari Refs
gnanasakthy
 
DeSantisJacksonDuncanReese2016
DeSantisJacksonDuncanReese2016DeSantisJacksonDuncanReese2016
DeSantisJacksonDuncanReese2016
Barry Duncan
 
Application of Pharma Economic Evaluation Tools for Analysis of Medical Condi...
Application of Pharma Economic Evaluation Tools for Analysis of Medical Condi...Application of Pharma Economic Evaluation Tools for Analysis of Medical Condi...
Application of Pharma Economic Evaluation Tools for Analysis of Medical Condi...
IJREST
 
THE MERITS OF EVIDENCE BASED MEDICINE IN MEDICAL INFORMATION JUNGLE
THE MERITS OF EVIDENCE BASED MEDICINE IN MEDICAL INFORMATION JUNGLETHE MERITS OF EVIDENCE BASED MEDICINE IN MEDICAL INFORMATION JUNGLE
THE MERITS OF EVIDENCE BASED MEDICINE IN MEDICAL INFORMATION JUNGLE
International Educational Applied Scientific Research Journal (IEASRJ)
 
A Model For Pharmacological Research Treatment Of Cocaine Dependence
A Model For Pharmacological Research Treatment Of Cocaine DependenceA Model For Pharmacological Research Treatment Of Cocaine Dependence
A Model For Pharmacological Research Treatment Of Cocaine Dependence
Richard Hogue
 
MEDICATION RECONCILIATION INTERVENTIONS PRACTICE RESEARCH REPO.docx
MEDICATION RECONCILIATION INTERVENTIONS PRACTICE RESEARCH REPO.docxMEDICATION RECONCILIATION INTERVENTIONS PRACTICE RESEARCH REPO.docx
MEDICATION RECONCILIATION INTERVENTIONS PRACTICE RESEARCH REPO.docx
ARIV4
 
humanastatinarticle
humanastatinarticlehumanastatinarticle
humanastatinarticlenewtonsapple
 
A systematic review of the quality of homeopathic clinical trials
A systematic review of the quality of homeopathic clinical trialsA systematic review of the quality of homeopathic clinical trials
A systematic review of the quality of homeopathic clinical trials
home
 
Article On Memantine-1.pptx
Article On Memantine-1.pptxArticle On Memantine-1.pptx
Article On Memantine-1.pptx
Nimish Savaliya
 
SLC CME- Evidence based medicine 07/27/2007
SLC CME- Evidence based medicine 07/27/2007SLC CME- Evidence based medicine 07/27/2007
SLC CME- Evidence based medicine 07/27/2007
cddirks
 
JRA 2.pdf
JRA 2.pdfJRA 2.pdf
JRA 2.pdf
shelladepari
 
Factors Affecting Non-Compliance among Psychiatric Patients in the Regional I...
Factors Affecting Non-Compliance among Psychiatric Patients in the Regional I...Factors Affecting Non-Compliance among Psychiatric Patients in the Regional I...
Factors Affecting Non-Compliance among Psychiatric Patients in the Regional I...
iosrphr_editor
 
Inhaled Corticosteroid Beliefs
Inhaled Corticosteroid BeliefsInhaled Corticosteroid Beliefs
Inhaled Corticosteroid BeliefsYaadira Brown
 
Running head CRITIQUE QUANTITATIVE, QUALITATIVE, OR MIXED METHODS.docx
Running head CRITIQUE QUANTITATIVE, QUALITATIVE, OR MIXED METHODS.docxRunning head CRITIQUE QUANTITATIVE, QUALITATIVE, OR MIXED METHODS.docx
Running head CRITIQUE QUANTITATIVE, QUALITATIVE, OR MIXED METHODS.docx
todd271
 
Meta analysis of clinical efficacy of pulsed radio frequency
Meta analysis of clinical efficacy of pulsed radio frequencyMeta analysis of clinical efficacy of pulsed radio frequency
Meta analysis of clinical efficacy of pulsed radio frequencyPainezee Specialist
 
What Works in Chronic Care Management 6.12.09
What Works in Chronic Care Management 6.12.09What Works in Chronic Care Management 6.12.09
What Works in Chronic Care Management 6.12.09
Leonard Davis Institute of Health Economics
 
Measuring to Improve Medication Reconciliationin a Large Sub.docx
Measuring to Improve Medication Reconciliationin a Large Sub.docxMeasuring to Improve Medication Reconciliationin a Large Sub.docx
Measuring to Improve Medication Reconciliationin a Large Sub.docx
alfredacavx97
 
Evidence based periodontology
Evidence based periodontologyEvidence based periodontology
Evidence based periodontology
Sumalatha Appam
 
Impact Of Computer Software Appplication On Medication Therapy Adherence
Impact Of Computer Software Appplication On Medication Therapy AdherenceImpact Of Computer Software Appplication On Medication Therapy Adherence
Impact Of Computer Software Appplication On Medication Therapy AdherenceYayra Nyoagbe
 

Similar to Pharmaceutical Comparative Effectiveness Research Abstract (20)

Application of Pharma Economic Evaluation Tools for Analysis of Medical Condi...
Application of Pharma Economic Evaluation Tools for Analysis of Medical Condi...Application of Pharma Economic Evaluation Tools for Analysis of Medical Condi...
Application of Pharma Economic Evaluation Tools for Analysis of Medical Condi...
 
Ari Refs
Ari RefsAri Refs
Ari Refs
 
DeSantisJacksonDuncanReese2016
DeSantisJacksonDuncanReese2016DeSantisJacksonDuncanReese2016
DeSantisJacksonDuncanReese2016
 
Application of Pharma Economic Evaluation Tools for Analysis of Medical Condi...
Application of Pharma Economic Evaluation Tools for Analysis of Medical Condi...Application of Pharma Economic Evaluation Tools for Analysis of Medical Condi...
Application of Pharma Economic Evaluation Tools for Analysis of Medical Condi...
 
THE MERITS OF EVIDENCE BASED MEDICINE IN MEDICAL INFORMATION JUNGLE
THE MERITS OF EVIDENCE BASED MEDICINE IN MEDICAL INFORMATION JUNGLETHE MERITS OF EVIDENCE BASED MEDICINE IN MEDICAL INFORMATION JUNGLE
THE MERITS OF EVIDENCE BASED MEDICINE IN MEDICAL INFORMATION JUNGLE
 
A Model For Pharmacological Research Treatment Of Cocaine Dependence
A Model For Pharmacological Research Treatment Of Cocaine DependenceA Model For Pharmacological Research Treatment Of Cocaine Dependence
A Model For Pharmacological Research Treatment Of Cocaine Dependence
 
MEDICATION RECONCILIATION INTERVENTIONS PRACTICE RESEARCH REPO.docx
MEDICATION RECONCILIATION INTERVENTIONS PRACTICE RESEARCH REPO.docxMEDICATION RECONCILIATION INTERVENTIONS PRACTICE RESEARCH REPO.docx
MEDICATION RECONCILIATION INTERVENTIONS PRACTICE RESEARCH REPO.docx
 
humanastatinarticle
humanastatinarticlehumanastatinarticle
humanastatinarticle
 
A systematic review of the quality of homeopathic clinical trials
A systematic review of the quality of homeopathic clinical trialsA systematic review of the quality of homeopathic clinical trials
A systematic review of the quality of homeopathic clinical trials
 
Article On Memantine-1.pptx
Article On Memantine-1.pptxArticle On Memantine-1.pptx
Article On Memantine-1.pptx
 
SLC CME- Evidence based medicine 07/27/2007
SLC CME- Evidence based medicine 07/27/2007SLC CME- Evidence based medicine 07/27/2007
SLC CME- Evidence based medicine 07/27/2007
 
JRA 2.pdf
JRA 2.pdfJRA 2.pdf
JRA 2.pdf
 
Factors Affecting Non-Compliance among Psychiatric Patients in the Regional I...
Factors Affecting Non-Compliance among Psychiatric Patients in the Regional I...Factors Affecting Non-Compliance among Psychiatric Patients in the Regional I...
Factors Affecting Non-Compliance among Psychiatric Patients in the Regional I...
 
Inhaled Corticosteroid Beliefs
Inhaled Corticosteroid BeliefsInhaled Corticosteroid Beliefs
Inhaled Corticosteroid Beliefs
 
Running head CRITIQUE QUANTITATIVE, QUALITATIVE, OR MIXED METHODS.docx
Running head CRITIQUE QUANTITATIVE, QUALITATIVE, OR MIXED METHODS.docxRunning head CRITIQUE QUANTITATIVE, QUALITATIVE, OR MIXED METHODS.docx
Running head CRITIQUE QUANTITATIVE, QUALITATIVE, OR MIXED METHODS.docx
 
Meta analysis of clinical efficacy of pulsed radio frequency
Meta analysis of clinical efficacy of pulsed radio frequencyMeta analysis of clinical efficacy of pulsed radio frequency
Meta analysis of clinical efficacy of pulsed radio frequency
 
What Works in Chronic Care Management 6.12.09
What Works in Chronic Care Management 6.12.09What Works in Chronic Care Management 6.12.09
What Works in Chronic Care Management 6.12.09
 
Measuring to Improve Medication Reconciliationin a Large Sub.docx
Measuring to Improve Medication Reconciliationin a Large Sub.docxMeasuring to Improve Medication Reconciliationin a Large Sub.docx
Measuring to Improve Medication Reconciliationin a Large Sub.docx
 
Evidence based periodontology
Evidence based periodontologyEvidence based periodontology
Evidence based periodontology
 
Impact Of Computer Software Appplication On Medication Therapy Adherence
Impact Of Computer Software Appplication On Medication Therapy AdherenceImpact Of Computer Software Appplication On Medication Therapy Adherence
Impact Of Computer Software Appplication On Medication Therapy Adherence
 

More from Lona Vincent

Fox Feed Blog - MJFF drives conversation around payment for parkinson’s care
Fox Feed Blog - MJFF drives conversation around payment for parkinson’s care Fox Feed Blog - MJFF drives conversation around payment for parkinson’s care
Fox Feed Blog - MJFF drives conversation around payment for parkinson’s care
Lona Vincent
 
MKA Article - Engaging payers in Parkinson's Drug Development
MKA Article -  Engaging payers in Parkinson's Drug DevelopmentMKA Article -  Engaging payers in Parkinson's Drug Development
MKA Article - Engaging payers in Parkinson's Drug Development
Lona Vincent
 
Overcoming obstacles to repurposing for neurodegenerative disease
Overcoming obstacles to repurposing for neurodegenerative diseaseOvercoming obstacles to repurposing for neurodegenerative disease
Overcoming obstacles to repurposing for neurodegenerative disease
Lona Vincent
 
GTC 2nd neurological biomarkers 2013 poster
GTC 2nd neurological biomarkers 2013 posterGTC 2nd neurological biomarkers 2013 poster
GTC 2nd neurological biomarkers 2013 poster
Lona Vincent
 
The BioFIND study (Fox investigation for new discovery of biomarkers in parki...
The BioFIND study (Fox investigation for new discovery of biomarkers in parki...The BioFIND study (Fox investigation for new discovery of biomarkers in parki...
The BioFIND study (Fox investigation for new discovery of biomarkers in parki...
Lona Vincent
 
MJFF Regulatory Meeting on Cognition - Alzheimer's Research Forum Summary
MJFF Regulatory Meeting on Cognition - Alzheimer's Research Forum SummaryMJFF Regulatory Meeting on Cognition - Alzheimer's Research Forum Summary
MJFF Regulatory Meeting on Cognition - Alzheimer's Research Forum Summary
Lona Vincent
 
Therapeutic Development Paths for Cognitive Impairment in Parkinson's Disease...
Therapeutic Development Paths for Cognitive Impairment in Parkinson's Disease...Therapeutic Development Paths for Cognitive Impairment in Parkinson's Disease...
Therapeutic Development Paths for Cognitive Impairment in Parkinson's Disease...
Lona Vincent
 
Pharmaceutical Risk Benefit Assessment DIA Abstract
Pharmaceutical Risk Benefit Assessment DIA AbstractPharmaceutical Risk Benefit Assessment DIA Abstract
Pharmaceutical Risk Benefit Assessment DIA AbstractLona Vincent
 
Pharmaceutical Lifecycle Management Presentation
Pharmaceutical Lifecycle Management PresentationPharmaceutical Lifecycle Management Presentation
Pharmaceutical Lifecycle Management PresentationLona Vincent
 
Harvard Comparative Effectiveness - Pharmaceutical
Harvard Comparative Effectiveness - PharmaceuticalHarvard Comparative Effectiveness - Pharmaceutical
Harvard Comparative Effectiveness - Pharmaceutical
Lona Vincent
 

More from Lona Vincent (10)

Fox Feed Blog - MJFF drives conversation around payment for parkinson’s care
Fox Feed Blog - MJFF drives conversation around payment for parkinson’s care Fox Feed Blog - MJFF drives conversation around payment for parkinson’s care
Fox Feed Blog - MJFF drives conversation around payment for parkinson’s care
 
MKA Article - Engaging payers in Parkinson's Drug Development
MKA Article -  Engaging payers in Parkinson's Drug DevelopmentMKA Article -  Engaging payers in Parkinson's Drug Development
MKA Article - Engaging payers in Parkinson's Drug Development
 
Overcoming obstacles to repurposing for neurodegenerative disease
Overcoming obstacles to repurposing for neurodegenerative diseaseOvercoming obstacles to repurposing for neurodegenerative disease
Overcoming obstacles to repurposing for neurodegenerative disease
 
GTC 2nd neurological biomarkers 2013 poster
GTC 2nd neurological biomarkers 2013 posterGTC 2nd neurological biomarkers 2013 poster
GTC 2nd neurological biomarkers 2013 poster
 
The BioFIND study (Fox investigation for new discovery of biomarkers in parki...
The BioFIND study (Fox investigation for new discovery of biomarkers in parki...The BioFIND study (Fox investigation for new discovery of biomarkers in parki...
The BioFIND study (Fox investigation for new discovery of biomarkers in parki...
 
MJFF Regulatory Meeting on Cognition - Alzheimer's Research Forum Summary
MJFF Regulatory Meeting on Cognition - Alzheimer's Research Forum SummaryMJFF Regulatory Meeting on Cognition - Alzheimer's Research Forum Summary
MJFF Regulatory Meeting on Cognition - Alzheimer's Research Forum Summary
 
Therapeutic Development Paths for Cognitive Impairment in Parkinson's Disease...
Therapeutic Development Paths for Cognitive Impairment in Parkinson's Disease...Therapeutic Development Paths for Cognitive Impairment in Parkinson's Disease...
Therapeutic Development Paths for Cognitive Impairment in Parkinson's Disease...
 
Pharmaceutical Risk Benefit Assessment DIA Abstract
Pharmaceutical Risk Benefit Assessment DIA AbstractPharmaceutical Risk Benefit Assessment DIA Abstract
Pharmaceutical Risk Benefit Assessment DIA Abstract
 
Pharmaceutical Lifecycle Management Presentation
Pharmaceutical Lifecycle Management PresentationPharmaceutical Lifecycle Management Presentation
Pharmaceutical Lifecycle Management Presentation
 
Harvard Comparative Effectiveness - Pharmaceutical
Harvard Comparative Effectiveness - PharmaceuticalHarvard Comparative Effectiveness - Pharmaceutical
Harvard Comparative Effectiveness - Pharmaceutical
 

Recently uploaded

Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 

Recently uploaded (20)

Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 

Pharmaceutical Comparative Effectiveness Research Abstract

  • 1. VALUE IN HEALTH 14 (2011) A1–A214 A25 termination. CONCLUSIONS: Clinical trial learning curves have significant impli- were published in 15 different journals all based outside of Russia between 1994 cations for outcomes research accuracy, patient safety, and overall trial success. and 2009. On average, each article was written by seven authors. Most first authors Clinical trial simulation may provide a broadly applicable methodology for ad- had medical/clinical training and resided in the USA (n 8) at the time of publica- dressing several factors associated with clinical trial learning curve effects and for tion of the study. Based on a scale of 1–10, with 10 indicating the highest quality, the improving the accuracy of clinical trial outcomes. mean quality score for all studies was 8.09 (SD 1.29) and 25% of the articles were of fair quality (score 5–7). The quality of articles was statistically significantly re- PHP75 lated (P 0.05) to the primary health intervention (pharmaceuticals non-phar- USE OF ELECTRONIC MEDICAL RECORDS FROM 2001 THROUGH 2010: maceuticals) and primary training of the first author (medical non-medical). IMPLICATIONS FOR COMPARATIVE EFFECTIVENESS RESEARCH CONCLUSIONS: The conduct of health economics and pharmacoeconomics research Anastassopoulos KP1, Mann R2, Knight TG1, Sudharshan L1, Ackerman SJ2 1 in Russia in the English language is limited and, on average, the published articles Covance Market Access Services, Inc., Gaithersburg, MD, USA, 2Covance Market Access Services, Inc., San Diego, CA, USA were of good quality. However, about one-quarter of published articles were of fair OBJECTIVES: Recent developments in the United States (US) health care reform quality. More health economics research in English is warranted in Russia. and funding for comparative effectiveness research suggest that use of electronic PHP78 medical records (EMR) in outcomes research may increase over time. EMR can be CHARACTERISTICS OF HOMELESS INDIVIDUALS USING INPATIENT AND particularly useful when outcomes are not well-defined with diagnosis or proce- EMERGENCY DEPARTMENT SERVICES dures codes or when clinical data are needed. The objective of this study was to Karaca Z, Wong H, Mutter R review trends in the use of EMR during the past decade. METHODS: A review of Agency for Healthcare Research and Quality (AHRQ), Rockville, MD, USA published literature was conducted in PubMed for years 2001 through 2010 to iden- OBJECTIVES: This study compares the patient characteristics, insurance coverage, tify outcomes studies in the US that used EMR. Internal quality assurance studies disease prevalence, and utilization patterns of inpatient and emergency depart- and validation studies that used EMR were excluded. The number of studies, set- ment (ED) services between homeless and non-homeless people using a new data ting of care, patient population, whether the study was comparative, and any noted source that has not been employed in existing studies. METHODS: A retrospective limitations were examined. RESULTS: A total of 58 EMR-based, outcomes studies in data analysis was conducted to compare differences in patient characteristics, the US were identified over the past decade; increasing from 3 in 2001 to 12 in 2010. insurance coverage, disease prevalence, and utilization patterns between home- The majority of studies included outpatient EMR. Studies included a variety of less and non-homeless individuals who visited a hospital or hospital-based emer- patient populations with over one-third in cardiovascular disease, psychiatric dis- gency department. For each service type, separate rates were created for homeless ease, and diabetes combined. The percent of studies that were comparative ranged and non-homeless populations and then compared. The Healthcare Cost and Uti- from 0% in 2001 to 45% in 2010. Measures of effectiveness varied widely and in- lization Project (HCUP) State Inpatient Databases (SID) and State Emergency De- cluded lab values, clinical measures, and health-related quality-of-life outcomes. partment Databases (SEDD) for 2008 were used in the analysis. The SID employed in Some noted limitations on the use of EMR data in outcomes research included lack this study include 15.9 million inpatient hospital discharges from community hos- of representativeness of all care delivered across practice settings, lack of general- pitals in ten states – Arizona, California, Colorado, Florida, Georgia, Massachusetts, izability and standardization, and reliance on health care provider reporting. Missouri, New York, Pennsylvania and Wisconsin. 177,056 of these discharges were CONCLUSIONS: Although the use of EMR in outcomes research has increased homeless patients. The SEDD employed in this study include 23.7 million visits to slowly in the past decade, the proportion of comparative studies using EMR has ED, where patients were treated and released, from seven states (i.e., Arizona, increased over time. As the industry works to standardize EMR and more advanced Florida, Georgia, Massachusetts, Missouri, New York and Wisconsin). 49,595 of outcomes are collected in EMR systems, EMR data may play a larger role in com- these visits were homeless patients. RESULTS: The uninsured homeless (non- parative effectiveness research. homeless) patients were accountable for 28.1% (4.6%) of inpatient admissions and 42.85 (21%) of ED visits. Medicaid covered 48.2% of all inpatient discharges and PHP76 34.7% of all ED visits by homeless patients. 73.7% (50.6%) of homeless (non-home- THE OUTLOOK OF LARGE SIMPLE TRIALS FOR COMPARATIVE EFFECTIVENESS less) inpatient admissions came through EDs. Homeless patients with mental dis- RESEARCH: AN APPLICATION OF THE PRECIS FRAMEWORK orders accounted for 22.4% of all homeless inpatient discharges and 49% of all Vincent L homeless ED visits. A majority of the mental disorder diagnosis in both settings of Quintiles Global Consulting, Hawthorne, NY, USA care were alcohol-related disorders, mood disorders, and schizophrenia. OBJECTIVES: In recent years, comparative effectiveness research (CER) has gained CONCLUSIONS: The profile of homeless and non-homeless patients differed sig- increasing interest and investment across major life science and health policy nificantly by insurance status and by race in both the inpatient and emergency stakeholder groups: regulators, biopharmaceuticals, physicians, patients, and pay- department settings. ers. One method, large simple trial (LST), a hybrid of observational cohort study and randomized control trial (RCT), is designed for large numbers of patients in post- PHP79 approval research and is a choice study design for comparing the relative strengths ROLE OF HTA SYSTEMS IN REIMBURSEMENT AND MARKET ACCESS: and weaknesses of medical interventions. The objective of this study was to eval- COMPARISON OF TURKEY AND POLAND uate the current landscape of LSTs to capture key themes in the future outlook of Kirpekar S, Shankland B, Dummett H CER. METHODS: A structured abstract review and funnel analysis was conducted Double Helix Consulting, London, UK using data available through ClinicalTrials.gov. Using the search terms, “phase IV”, OBJECTIVES: Health economies outside Western Europe are increasingly adopting “post-marketing”, “randomized”, and “multi-centered”, 2230 clinical trials were evidence-based decision-making, but implementation methods differ. Common- filtered with restricted parameters for number of patients (n 1000), evidence of alities in the approach taken in Turkey and Poland nevertheless illustrate the role blinding, stated objective of comparative effectiveness, and date of trial initiation. of a previously developed reimbursement process in the adoption of HTA. Insights RESULTS: To gain a perspective on current and future outlook, only trials initiated from this comparison may have implications for industry, government and private between 2009 and 2010 (n 10) were assessed in this phase of study. Using the reimbursement authorities worldwide. METHODS: Turkey and Poland were se- Pragmatic Explanatory Continuum Indicator Summary (PRECIS) framework origi- lected for comparison due to their relatively recent adoption of HTA within an nally developed for pragmatic trials, the analysis revealed an important theme. established reimbursement system. A total of 18 stakeholders were interviewed via When applying key domain criteria – practitioner expertise, treatment flexibility, telephone interviews to understand current and future utilisation of HTA in reim- eligibility criteria, health outcomes, study duration, intent-to-treat (ITT), and pri- bursement. The study evaluated the impact of the following decision-making do- mary outcome analysis, as defined by the PRECIS framework – less than 50% of the mains: clinical differentiation, prioritisation of unmet needs, price, and presenta- LST CER trials were designed to measure effectiveness, as opposed to efficacy. tion requirements (e.g. budget impact analysis). A comparison was then made on a CONCLUSIONS: According to findings, there has been an uptake on the use of LSTs rating scale devised to account for these influencing factors. RESULTS: In Turkey in investigating the relative effectiveness of interventions. However, considering the pharmacoeconomics unit of the Social Security Institute is responsible for the increase in governmental pressure to reduce healthcare spending by improving economic evaluation. However the Polish HTA body AHTAPol is more directly in- quality of treatment; it is important that these LSTs are conducted to truly capture volved in the HTA process. All 9 Polish respondents scored high on the influence of effectiveness. For that reason, there is need for further research to extract and HTA in access decisions while just 2 respondents in Turkey considered HTA to be develop new frameworks for evaluation. extremely influential in reimbursement. However, pricing decisions in both coun- tries are based on international referencing to varying degrees. CONCLUSIONS: PHP77 Despite superficial similarities in the structure of their reimbursement systems, THE STATE OF HEALTH ECONOMICS AND PHARMACOECONOMICS RESEARCH HTA in Poland is more closely integrated with decision making than in Turkey. At IN RUSSIA: A SYSTEMATIC REVIEW present HTA plays a formal role in the Turkish system but a negotiation-based Gavaza P1, Shepherd MD2, Shcherbakova N3, Khoza S3 approach remains to customary channel for value arguments. However, the rapid 1 Appalachian College of Pharmacy, Oakwood, VA, USA, 2Center for Pharmacoeconomic Studies, pace of change in the Turkish reimbursement system suggests the need for further College of Pharmacy, University of Texas at Austin, Austin, TX, USA, 3Division of Pharmacy ongoing research. Administration, College of Pharmacy, University of Texas at Austin, Austin, TX, USA OBJECTIVES: To investigate the state of health economic research in Russia avail- PHP80 able in the English language by describing the number and characteristics of the RELATIONSHIP OF HERBAL KNOWLEDGE TOWARDS ATTITUDE FORMATION articles, and assessing the quality of these articles. METHODS: The study assessed AMONG FUTURE PHARMACISTS the state of health economics and pharmacoeconomics research in Russia. We Sura SD, Chabria A, Sansgiry S conducted a literature search to identify health economics articles pertaining to University of Houston, Houston, TX, USA Russia. Each article in the final sample was scored by two reviewers independently OBJECTIVES: Trends in the use of herbal medications continue to rise. Pharmacists using the data-collection form designed for the study. RESULTS: In total, 16 studies have an opportunity to provide consumers with evidence based information. This investigating a wide variety of diseases were included in the study. These articles study examined pharmacy student’s knowledge regarding herbal medication from